ALZN

ALZN

Alzamend Neuro Inc

Net โ€”top 1%Rev โ€”top 1%5Y
Hold

Alzamend Neuro Inc. develops biopharmaceutical products targeting neurodegenerative and psychiatric disorders. Its pipeline includes treatments for Alzheimer's disease, bipolar disorder, PTSD, and major depressive disorder, utilizing therapeutic combinations and cell-based vaccines.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$0today

Score Overview

1 Year
Scoreโ€”
Net Growth-94.30%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trendโ€”
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growthโ€”
Net Trendโ€”
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trendโ€”
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth29.04%
Net Trend50%
Net Income Consistency
Rev Growthโ€”
Rev TrendNever
Revenue Consistencyโ€”

See the full market ranking โ†’

Alzamend Neuro Inc fundamental performance

Across Alzamend Neuro Inc's full reported history, from 2022 to 2026, net income went from -$ 12M to -$ 8M. Revenue increased in 0% of the years measured; net income in 50%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.44โ€”
1 Year2025-08-12
$ 2.44-40.98%
5 Years2021-08-12
$ 5.17K-99.97%
All Time2021-06-15
$ 18.23K-99.99%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026-$ 8M$ 710.69K
2025$ 0.00-$ 4M$ 3M
2024$ 0.00-$ 9M$ 376.05K
2023$ 0.00-$ 14M$ 5M
2022$ 0.00-$ 12M$ 14M

Explore beyond ALZN

You're looking at Alzamend Neuro Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies